Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 541: What is the term for the time between the first possible point of diagnosis and the final critical point of a disease?

A. Lag time
B. Lead time
C. Screening time (Correct Answer)
D. Log time

Explanation: ### Explanation The correct answer is **Screening time**. **1. Understanding the Concept** In the natural history of a disease, the **Screening Time** (also known as the *detectable preclinical phase*) refers to the interval between the earliest point at which a disease can be detected by a screening test and the **final critical point**. The final critical point is the moment in the disease progression after which treatment becomes ineffective or the prognosis cannot be changed. Identifying a disease during this "screening time" is the fundamental goal of secondary prevention. **2. Analysis of Options** * **Lead Time (Option B):** This is a high-yield distractor. Lead time is the period between the **detection of a disease by screening** and the **time of usual clinical diagnosis** (when symptoms would have appeared). While related, it measures the "advantage" gained by screening, whereas the question asks for the interval ending at the *critical point*. * **Lag Time (Option A):** In epidemiology, this usually refers to the delay between exposure to a risk factor and the clinical manifestation of a disease (common in chronic disease modeling). * **Log Time (Option D):** This is a mathematical term (logarithmic scale) used in growth curves (e.g., bacterial growth phases) and is not a standard epidemiological term for disease progression intervals. **3. NEET-PG High-Yield Pearls** * **Lead Time Bias:** This occurs when screening appears to increase survival time simply because the disease was detected earlier, even if the actual time of death remains unchanged. * **Length Bias:** Screening tends to detect slowly progressing cases (which have a longer screening time) rather than rapidly progressing ones, potentially overestimating the benefit of the program. * **Iceberg Phenomenon:** Screening aims to reveal the "submerged" portion of the iceberg (undiagnosed/preclinical cases). Hypertension and Diabetes are classic examples; Genetic diseases are NOT.

Question 542: What are the mechanisms by which cholera might be maintained during the intervals between peak cholera seasons?

A. Carrier status in animals
B. Carrier status in humans
C. An environmental reservoir
D. Continuous transmission in humans (Correct Answer)

Explanation: **Explanation:** The maintenance of cholera during inter-epidemic periods is a classic concept in the epidemiology of *Vibrio cholerae*. **1. Why "Continuous transmission in humans" is correct:** Cholera is primarily a human disease with no significant animal reservoir. During the intervals between peak seasons (the "off-season"), the infection is maintained through **subclinical cases** and **mild infections** that go unnoticed. This is known as **"smoldering" transmission**. Because the ratio of asymptomatic to symptomatic cases is high (up to 100:1 for El Tor biotype), the bacteria continue to circulate at low levels in the human population, providing a continuous source for the next outbreak when environmental conditions become favorable. **2. Why other options are incorrect:** * **Carrier status in animals (A):** Cholera is an anthroponotic disease; there are no known natural animal reservoirs that play a role in its maintenance. * **Carrier status in humans (B):** While humans can be carriers, the carrier state in cholera is typically **short-lived** (convalescent carriers shed for 2-3 weeks). Chronic carriers (like "Cholera Dolores") are extremely rare and do not contribute significantly to the large-scale maintenance of the disease. * **An environmental reservoir (C):** While *V. cholerae* can survive in aquatic environments (attached to copepods/zooplankton), the primary mechanism for maintaining the chain of infection between seasonal peaks is active, low-level human-to-human transmission. **NEET-PG High-Yield Pearls:** * **Ratio of Asymptomatic to Symptomatic:** 5:1 to 10:1 for Classical; **50:1 to 100:1 for El Tor** (making El Tor harder to eradicate). * **Incubation Period:** Very short, ranging from a few hours to 5 days (Average: 1-2 days). * **Most Common Source:** Contaminated water is the most common vehicle; however, the **human reservoir** is the ultimate source. * **Gold Standard Diagnosis:** Stool culture on **TCBS agar**.

Question 543: What is the recommended duration for the use of long-lasting insecticidal nets?

A. 6 months
B. 1 year
C. 3 years (Correct Answer)
D. 10 years

Explanation: ### Explanation **Correct Answer: C. 3 years** **1. Why it is correct:** Long-Lasting Insecticidal Nets (LLINs) are a core intervention in the Global Malaria Program. Unlike traditional Insecticide-Treated Nets (ITNs) that require re-treatment every 6–12 months, LLINs are manufactured by permanently incorporating or coating insecticide (usually pyrethroids) into the fibers. According to WHO guidelines and the National Vector Borne Disease Control Programme (NVBDCP), an LLIN is designed to maintain its biological efficacy against mosquitoes for **at least 3 years** or 20 standard washes under field conditions. **2. Why the other options are incorrect:** * **A & B (6 months / 1 year):** These durations are typical for conventional ITNs, which lose their insecticide concentration rapidly after a few washes and require periodic "dipping" in insecticide. * **D (10 years):** No current LLIN technology guarantees insecticide stability or physical integrity (resistance to tearing) for a decade. Using a net beyond its efficacy period increases the risk of malaria transmission. **3. High-Yield Clinical Pearls for NEET-PG:** * **Insecticide Used:** Primarily **Pyrethroids** (e.g., Permethrin, Deltamethrin, Alpha-cypermethrin). * **Mechanism:** LLINs provide a "double-action" protection—a **physical barrier** and a **chemical repellent/killing effect** (knockdown effect). * **Target Population:** Under the National Framework for Malaria Elimination in India, LLINs are distributed free of cost in high-burden areas (API > 2). * **Maintenance:** LLINs should be washed with cold water and mild soap and dried in the **shade** (direct sunlight degrades the insecticide). * **The "3-20" Rule:** Remember LLINs for **3** years or **20** washes.

Question 544: A medical officer confirms the diagnosis of polio in one of their patients. This can be considered as:

A. Endemic
B. Epidemic (Correct Answer)
C. Sporadic case
D. Pandemic

Explanation: ### Explanation **1. Why "Epidemic" is the Correct Answer:** In epidemiology, an **epidemic** is defined as the occurrence of cases of an illness in a community or region clearly in excess of normal expectancy. For diseases targeted for **eradication or elimination** (like Polio or Measles), the "normal expectancy" is zero. Therefore, even a **single case** of such a disease is considered an epidemic. Since India is certified Polio-free (since 2014), any new confirmed case represents a major public health emergency and a breach of immunity, fitting the definition of an epidemic. **2. Why Other Options are Incorrect:** * **Endemic:** Refers to the constant presence of a disease or infectious agent within a given geographic area or population group (e.g., Malaria in certain parts of India). Polio is no longer endemic in India. * **Sporadic:** Refers to cases that occur irregularly, haphazardly, and are scattered from each other in time and space. While a single case might seem "scattered," the public health significance of Polio elevates it to an epidemic status. * **Pandemic:** An epidemic that spreads across several countries or continents, usually affecting a large number of people (e.g., COVID-19). A single case in one patient does not meet the geographical scale of a pandemic. **3. NEET-PG Clinical Pearls:** * **Zero Case Policy:** For diseases like Polio, Smallpox, and Guinea worm, **1 case = Epidemic**. * **Polio Eradication:** India received its Polio-free certification from the WHO on **March 27, 2014**, after three consecutive years of zero cases (last case was in Howrah, West Bengal, 2011). * **Surveillance:** The standard for Polio is **AFP (Acute Flaccid Paralysis) Surveillance**. The target non-polio AFP rate should be >2 per 100,000 children under 15 years. * **Outbreak vs. Epidemic:** These terms are often used interchangeably, but "outbreak" is typically used for a localized epidemic (e.g., in a hospital or village).

Question 545: A screening test is considered more sensitive if it has which of the following characteristics?

A. Few false negatives (Correct Answer)
B. Few false positives
C. More false positives
D. More false negatives

Explanation: **Explanation:** **Sensitivity** is defined as the ability of a screening test to correctly identify those who actually have the disease (True Positives). Mathematically, it is calculated as: **Sensitivity = [TP / (TP + FN)] × 100** **Why Option A is Correct:** Sensitivity is inversely related to the number of **False Negatives (FN)**. A highly sensitive test is "good at catching cases"; therefore, it rarely misses people who have the disease. If a test has "few false negatives," the denominator (TP + FN) stays close to the numerator (TP), resulting in a value near 100%. In clinical practice, a highly sensitive test is used for **screening** because a negative result effectively "rules out" the disease (SNOUT). **Why Other Options are Incorrect:** * **B. Few false positives:** This is a characteristic of **Specificity**. A test with few false positives is good at "ruling in" a disease (SPIN). * **C. More false positives:** This would decrease the Specificity and the Positive Predictive Value (PPV) of the test, but it does not directly define sensitivity. * **D. More false negatives:** This would significantly **decrease** sensitivity, as the test would miss many diseased individuals. **High-Yield Clinical Pearls for NEET-PG:** * **SNOUT:** **S**ensitivity **N**egative result rules **OUT** the disease. * **SPIN:** **S**pecificity **P**ositive result rules **IN** the disease. * **Screening vs. Diagnosis:** Screening tests require high **Sensitivity** (to avoid missing cases), while confirmatory/diagnostic tests require high **Specificity** (to avoid false labeling). * **Ideal Test:** Has 100% Sensitivity and 100% Specificity (rare in practice).

Question 546: Which vaccine is recommended for healthcare workers?

A. Human Immunodeficiency Virus (HIV)
B. Hepatitis B Virus (HBV) (Correct Answer)
C. Hepatitis C Virus (HCV)
D. Cholera

Explanation: **Explanation:** **Hepatitis B Virus (HBV)** is the correct answer because healthcare workers (HCWs) are at a high occupational risk of exposure to blood-borne pathogens via needle-stick injuries or mucosal splashes. HBV is highly infectious; the risk of transmission after a percutaneous injury from an HBeAg-positive source is approximately 30%. The HBV vaccine is a recombinant DNA vaccine that is safe, effective, and universally recommended for all HCWs to prevent chronic infection and its complications (cirrhosis and hepatocellular carcinoma). **Analysis of Incorrect Options:** * **HIV (Option A):** Currently, there is no approved vaccine for HIV due to the virus's high mutation rate and complex evasion of the immune system. Prevention relies on Post-Exposure Prophylaxis (PEP) and universal precautions. * **Hepatitis C (Option C):** There is no vaccine available for HCV. Like HIV, prevention in healthcare settings depends on stringent infection control and prompt management of occupational exposure. * **Cholera (Option D):** This is a water-borne disease. While oral cholera vaccines exist, they are primarily used for travelers to endemic areas or during outbreaks in areas with poor sanitation. It is not a routine occupational requirement for HCWs. **High-Yield Clinical Pearls for NEET-PG:** * **HBV Schedule:** The standard adult schedule is 0, 1, and 6 months (Intramuscular, Deltoid muscle). * **Post-Vaccination Testing:** Anti-HBs titers should be checked 1–2 months after the third dose. A titer **≥10 mIU/mL** indicates adequate protection. * **Non-responders:** If titers are <10 mIU/mL after the first series, a second 3-dose series is recommended. * **Rule of 3s (Transmission risk after needle-stick):** HBV (30%), HCV (3%), HIV (0.3%).

Question 547: Which of the following statements about attack rate is FALSE?

A. It is a type of incidence rate (Correct Answer)
B. It is expressed as a percentage
C. It reflects the extent of an epidemic
D. The total population at risk is taken as the denominator

Explanation: ### Explanation **1. Why Option A is the correct (False) statement:** While the **Attack Rate** is conceptually related to incidence, it is technically a **ratio or a proportion**, not a true "rate." In epidemiology, a true rate must include a specific unit of time in the denominator (e.g., person-years). The Attack Rate measures the proportion of a population that develops a disease during a specific outbreak period, but it does not incorporate time into the denominator. Therefore, calling it a "rate" is a misnomer. **2. Analysis of other options:** * **Option B (Expressed as a percentage):** This is **true**. Unlike the standard incidence rate (usually per 1,000), the attack rate is almost always expressed as a percentage (per 100) to show the proportion of the population affected. * **Option C (Reflects the extent of an epidemic):** This is **true**. Attack rates are specifically used in outbreak investigations (e.g., food poisoning) to determine the speed and scale of spread within a defined group. * **Option D (Total population at risk as denominator):** This is **true**. The formula is: *(Number of new cases / Total population at risk at the beginning of the period) × 100.* ### High-Yield NEET-PG Pearls * **Secondary Attack Rate (SAR):** Measures the spread of an infectious disease from a primary case to contacts within a household or closed group. It is a key indicator of **communicability** (infectivity). * **Denominator for SAR:** Total number of susceptible contacts (excluding the primary case). * **Incidence vs. Prevalence:** Incidence (New cases) reflects **etiology/risk**; Prevalence (Old + New cases) reflects the **burden** of disease. * **Attack Rate** is used for short-term outbreaks; **Incidence** is used for long-term monitoring.

Question 548: Who is considered the Father of Epidemiology?

A. Hippocrates
B. John Snow (Correct Answer)
C. Ambroise Pare
D. Rudolf Virchow

Explanation: **Explanation:** **John Snow (Option B)** is recognized as the "Father of Epidemiology" due to his pioneering work during the 1854 cholera outbreak in London. He utilized a systematic approach—mapping cases (the "Ghost Map") and identifying the Broad Street pump as the source—to prove that cholera was waterborne. This was the first major application of descriptive and analytical epidemiology, occurring even before the germ theory of disease was established. **Analysis of Incorrect Options:** * **Hippocrates (Option A):** Known as the "Father of Medicine." He was the first to suggest that disease was not due to superstition but was influenced by environmental factors (Air, Water, and Places), making him the "First Epidemiologist," but not the Father of the modern discipline. * **Ambroise Pare (Option C):** A famous French surgeon known as the "Father of Modern Surgery." He revolutionized the treatment of gunshot wounds and stopped the practice of cauterizing them with boiling oil. * **Rudolf Virchow (Option D):** Known as the "Father of Modern Pathology" and the "Father of Social Medicine." He famously stated that "medicine is a social science" and emphasized the role of socio-economic factors in health. **High-Yield Clinical Pearls for NEET-PG:** * **John Snow’s Method:** He used a "Natural Experiment" (comparing households supplied by different water companies) to study cholera. * **James Lind:** Conducted the first clinical trial (scurvy and citrus fruits). * **Edward Jenner:** Father of Immunology (Smallpox vaccine). * **William Farr:** Father of Vital Statistics (developed the first classification of diseases).

Question 549: The completed family size may be estimated by:

A. Birth rate
B. Death rate
C. Total fertility rate (Correct Answer)
D. Age-specific fertility rate

Explanation: **Explanation:** **1. Why Total Fertility Rate (TFR) is correct:** The Total Fertility Rate is defined as the average number of children a woman would have if she were to pass through her entire reproductive period (15–49 years) experiencing the current age-specific fertility rates. It is considered the best indicator of the **completed family size** because it represents the total number of children a woman is expected to bear by the end of her childbearing years. **2. Why other options are incorrect:** * **Birth Rate (Crude Birth Rate):** This is a measure of the number of live births per 1,000 population per year. It is a "crude" measure because it includes the entire population (males, children, and elderly) in the denominator, rather than just the population at risk (women of reproductive age). * **Death Rate (Crude Death Rate):** This measures mortality within a population and has no direct correlation with estimating family size or fertility trends. * **Age-Specific Fertility Rate (ASFR):** This measures the number of live births per 1,000 women in a specific age group (e.g., 20–24 years). While TFR is calculated using ASFRs, a single ASFR only provides a "snapshot" of one age group and does not represent the completed family size. **High-Yield NEET-PG Pearls:** * **Replacement Level Fertility:** A TFR of **2.1** is considered the replacement level, where a population exactly replaces itself from one generation to the next without migration. * **Current Status:** India has achieved a TFR of **2.0** (as per NFHS-5), which is below the replacement level. * **Net Reproduction Rate (NRR):** While TFR counts all children, NRR counts only the number of **daughters** a newborn girl will bear. An NRR of 1 is the demographic goal of the National Health Policy.

Question 550: What is the denominator used when calculating the incidence rate?

A. Total observed population
B. Total population at risk during a specified period (Correct Answer)
C. Total live births
D. Total new cases in a given year

Explanation: ### Explanation **1. Why the Correct Answer is Right:** Incidence measures the number of **new cases** occurring in a defined population during a specific period. The denominator must represent the **population at risk**—individuals who are currently free of the disease but have the potential to develop it. For example, when calculating the incidence of cervical cancer, the denominator should only include women, as men are not "at risk." Using the population at risk ensures that the rate accurately reflects the speed or probability of new disease occurrence. **2. Analysis of Incorrect Options:** * **A. Total observed population:** This is too broad. It may include people who already have the disease (prevalent cases) or those who are naturally immune or biologically incapable of contracting the disease. * **C. Total live births:** This is the specific denominator used for mortality and morbidity indicators related to maternal and child health, such as the Infant Mortality Rate (IMR) or Maternal Mortality Ratio (MMR), not general incidence. * **D. Total new cases in a given year:** This is the **numerator** for calculating the incidence rate, not the denominator. **3. High-Yield Clinical Pearls for NEET-PG:** * **Incidence = (Number of new cases / Population at risk) × 1000.** * **Key Distinction:** Incidence is for **new cases** (acute conditions), while Prevalence is for **all cases** (old + new; chronic conditions). * **Relationship:** Prevalence = Incidence × Mean Duration of disease ($P = I \times D$). * **Special Types of Incidence:** * **Attack Rate:** A type of incidence used specifically during outbreaks/epidemics (expressed as a percentage). * **Secondary Attack Rate:** Measures the spread of disease from a primary case to contacts within a household or closed group; it reflects the **communicability** of an infectious agent.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free